Literature DB >> 6311278

Generation of hydroxyl radicals during the enzymatic reductions of the Fe3+-ADP-phosphate-adriamycin and Fe3+-ADP-EDTA systems. Less involvement of hydroxyl radical and a great importance of proposed perferryl ion complexes in lipid peroxidation.

K Sugioka, H Nakano, M Nakano, S Tero-Kubota, Y Ikegami.   

Abstract

A system which contains NADPH, purified cytochrome P-450 reductase (enzyme) and Fe3+-ADP-adriamycin complex in Tris-HCl buffer does not produce hydroxyl radical, but possesses a strong lipid peroxidation activity on exogenously added phospholipid micelles. Fe3+-ADP-adriamycin complex, a tightly coordinated complex in Tris-HCl buffer, could be dissociated to Fe3+-ADP-phosphate complex and adriamycin in phosphate buffer. Hydroxyl radical, which can be detected by a spin trapping method using N-tert-butyl-alpha-phenylnitrone, is produced during the enzymatic reduction of a mixture of Fe3+-ADP-phosphate complex and adriamycin or of Fe3+-ADP-EDTA complex while it is not involved in phospholipid peroxidation under the conditions used. With hydroxyl radical-generating systems, little or no quenching of hydroxyl radical in Tris-HCl buffer could be demonstrated. The oxidative cleavage of phospholipid is initiated by the proposed perferryl ion complex, which may be generated by the interaction of Fe2+-ADP-adriamycin complex with O2. A similar perferryl ion complex is also produced during the enzymatic reduction of Fe3+-ADP-EDTA complex with a molar ratio of 2 for [Fe3+]/[EDTA] in the presence of air. This is also able to catalyze lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311278     DOI: 10.1016/0005-2760(83)90065-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  Catecholamines and virulence of Cryptococcus neoformans.

Authors:  I Polacheck; Y Platt; J Aronovitch
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

Review 3.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

Review 4.  Oxidative stress in chemical toxicity.

Authors:  H Kappus
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

5.  Cardioprotection with ICRF-187 (Cardioxane) in patients with advanced breast cancer having cardiac risk factors for doxorubicin cardiotoxicity, treated with the FDC regimen.

Authors:  S Jelić; S Radulović; Z Nesković-Konstantinović; M Kreacić; Z Ristović; S Bosnjak; N Milanović; L Vuletić
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

6.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

7.  Enhancement of lysosomal enzyme activity by recombinant human tumor necrosis factor and its role in tumor cell killing in vitro.

Authors:  N Watanabe; N Yamauchi; H Neda; M Maeda; Y Tsuji; T Okamoto; S Akiyama; H Sasaki; N Tsuji; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-06

8.  Mechanism of synergistic cytotoxic effect between tumor necrosis factor and hyperthermia.

Authors:  N Yamauchi; N Watanabe; M Maeda; T Okamoto; H Sasaki; N Tsuji; Y Tsuji; H Umeno; S Akiyama; Y Niitsu
Journal:  Jpn J Cancer Res       Date:  1992-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.